Clarus Wealth Advisors Alnylam Pharmaceuticals, Inc. Transaction History

Clarus Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 11, 2019	SELL	$70.9 - $87.82 $13,471 - $16,685	-190 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$62.67 - $88.33 $5,953 - $8,391	95 Added 100.0%	190 $14,000
Q4 2018 Jan 08, 2019	BUY	$62.67 - $88.33 $5,953 - $8,391	95 New	95 $8,000
Q4 2018 Jan 07, 2019	SELL	$62.67 - $88.33 $5,953 - $8,391	-95 Closed	0 $0
Q3 2018 Oct 03, 2018	BUY	$87.52 - $122.67 $8,314 - $11,653	95 New	95 $8,000

643

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $28.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.